Venous thromboembolism and anticoagulant therapy in pregnancy

Gender Medicine

Volumn 2, Issue SUPPL. A, 2005, Pages

  Greer, Ian A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Coumarin; Heparin; Low molecular weight heparin; Pregnancy; Thrombophilia; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COUMARIN; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN; WARFARIN;

AGING; ANAMNESIS; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BONE DEMINERALIZATION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG SUBSTITUTION; EMBRYOPATHY; FAMILY HISTORY; FEMALE; FETAL HEMORRHAGE; FETUS OUTCOME; FETUS WASTAGE; HEART VALVE PROSTHESIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INFORMATION RETRIEVAL; INSTRUMENTAL DELIVERY; LOW DRUG DOSE; MATERNAL MORTALITY; MEDLINE; MORBIDITY; OBESITY; OSTEOPOROSIS; PHLEBOGRAPHY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TERATOGENICITY; THROMBOPHILIA; THROMBOSIS PREVENTION; TREATMENT CONTRAINDICATION; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL CARE; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS; WOMEN'S HEALTH;

EID: 33645018681     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1550-8579(05)80060-9     Document Type: Article

References (52)

1. Available at: http://www.cemach.org.uk/publications.htm CEMACH Why Mothers Die 2000-2002 2004 RCOG London
2. Macklon NS Greer IA Venous thromboembolic disease in obstetrics and gynaecology: The Scottish experience Scott Med J. 41 1996 83-86
3. for the Thromboembolic Pulmonary Hypertension Study Group Pengo V Lensing AW Prins MH et. al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism N Engl J Med. 350 2004 2257-2264
4. McColl M Ellison J Greer IA et. al. Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism Br J Haematol. 108 2000 272-274
5. Pabinger I Grafenhofer H Kyrle PA et. al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism Blood 100 2002 1060-1062
6. Robertson L Wu O Langhorne P et. al. Thrombophilia and pregnancy: A systematic review Br J Haematol. 125 Suppl 1 2005 35-36
7. McColl MD Ramsay JE Tait RC et. al. Risk factors for pregnancy associated venous thromboembolism Thromb Haemost. 78 1997 1183-1188
8. Kodama H Fukuda J Karube H et. al. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome Fertil Steril 66 1996 417-424
9. Arya R Shehata H Patel RK et. al. Internal jugular vein thrombosis after assisted conception therapy Br J Haematol. 115 2001 153-155
10. Samama MM An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: The Sirius study Arch Intern Med. 160 2000 3415-3420
11. Clarke P Brennand J Conkie JA et. al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy Thromb Haemost 79 1998 1166-1170
12. Macklon NS Greer IA Bowman AW An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy Br J Obstet Gynaecol. 104 1997 191-197
13. Macklon NS Greer IA The deep leg venous system in the puerperium. An ultrasound study Br J Obstet Gynaecol. 104 1997 198-200
14. Lindhagen A Bergqvist A Bergqvist D Hallbook T Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy Br J Obstet Gynaecol. 93 1986 348-352
15. Greer IA Thrombosis in pregnancy: Maternal and fetal issues Lancet 353 1999 1258-1265
16. Bates SM Greer IA Hirsh J Ginsberg JS Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Chest 126 2004 627S-644S
17. Vitale N De Feo M De Santo LS et. al. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves J Am Coll Cardiol 33 1999 1637-1641
18. Howe AM Webster WS The warfarin embryopathy: A rat model showing maxillonasal hypoplasia and other skeletal disturbances Teratology 46 1992 379-390
19. Wesseling J Van Driel D Heymans HS et. al. Coumarins during pregnancy: Long-term effects on growth and development in school-age children Thromb Haemost. 85 2001 609-613
20. Flessa HC Klapstrom AB Glueck HI Will JJ Placental transport of heparin Am J Obstet Gynecol 93 1965 570-573
21. Forestier F Daffos F Capella-Pavlovsky M Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ulstrasound Thromb Res. 34 1984 557-560
22. Forestier F Daffos F Rainaut M Toulemonde F Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy Thromb Haemost 57 1987 234
23. Nelson-Piercy C Hazards of heparin: Allergy, heparin-induced thrombocytopenia, and osteoporosis Greer IA Bailliere's Clinical Obstetrics and Gynaecology-Thromboembolic Disease in Obstetrics and Gynaecology 1997 Bailliere Tindall London, UK 489-509
24. Pettila V Leinonen P Markkola A et. al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin Thromb Haemost 87 2002 182-186
25. Warkentin TE Levine MN Hirsh J et. al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med. 332 1995 1330-1335
26. Nelson-Piercy C Letsky EA de Swiet M Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk Am J Obstet Gynecol 176 1997 1062-1068
27. Ellison J Walker ID Greer IA Antenatal use of enoxaparin for prevention and treatment of thromboem-bolism in pregnancy BJOG 107 2000 1116-1121
28. Lepercq J Conard J Borel-Derlon A et. al. Venous thromboembolism during pregnancy: A retrospective study of enoxaparin safety in 624 pregnancies BJOG 108 2001 1134-1140
29. Hunt BJ Doughty HA Majumdar G et. al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies Thromb Haemost. 77 1997 39-43
30. Blomback M Bremme K Hellgren M et. al. Thromboprophylaxis with low molecular mass heparin, 'Fragmin' (dalteparin), during pregnancy - ongitudinal safety study Blood Coagul Fibrinolysis 9 1988 1-9
31. Sanson BJ Lensing AW Prins MH et. al. Safety of low-molecular-weight heparin in pregnancy: A systematic review Thromb Haemost 81 1999 668-672
32. Greer IA Nelson-Piercy C Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy Blood 106 2005 401-407
33. Warkentin TE Greinacher A Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 311S-337S [published correction appears in. Chest 2005; 127:416]
34. Smith MP Norris LA Steer PJ et. al. Tinzaparin sodium for thrombosis treatment and prevention during pregnancy Am J Obstet Gynecol 190 2004 495-501
35. Norris LA Bonnar J Smith MP et. al. Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic study Thromb Haemost 92 2004 791-796
36. Byrd LM Johnston TA Shiach C Hay CR Osteoporotic fracture and low molecular weight heparin J Obstet Gynaecol 24 Suppl 1 2004 S11
37. for the Recurrence of Clot in This Pregnancy Study Group Brill-Edwards P Ginsberg JS Gent M et. al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism N Engl J Med 343 2000 1439-1444
38. Pabinger I Grafenhofer H Kaider A et. al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis J Thromb Haemost 3 2005 949-954
39. Available at http://www.rcog.org.uk Nelson-Piercy C Clinical Green Top Guideline Thromboprophylaxis during Pregnancy, Labour and after Vaginal Delivery (37) - RCOG London January 2004
40. Edinburgh Scottish Intercollegiate Guidelines Network Prophylaxis of venous thromboembolism. A national clinical guideline Available http://www.sign.ac.uk/guidelines/index.html at 2002 1 899893 03 2
41. Guideline No 28 Thomson AJ Greer IA Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management Available http://www.rcog.org.uk/ guidelines.asp?PageID=106&GuidelineID=20 at Royal College of Obstetricians and Gynaecologists 2001 RCOG Press London
42. Thromboembolism in pregnancy August 2000 American College of Obstetricians and Gynecologists (ACOG) Washington (DC) www.guideline.gov
43. Rodie VA Thomson AJ Stewart FM et. al. Low molecular weight heparin for the treatment of venous, thromboembolism in pregnancy: A case series BJOG 109 2002 1020-1024
44. Casele HL Laifer SA Woelkers DA Venkataramanan R Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy Am J Obstet Gynecol 181 1999 1113-1117
45. Thomson AJ Walker ID Greer IA Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy Lancet 352 1998 1904
46. Aschwanden M Labs KH Engel H et. al. Acute deep vein thrombosis: Early mobilization does not increase the frequency of pulmonary embolism Thromb Haemost 85 2001 42-46
47. Blattler W Partsch H Leg compression and ambulation is better than bed rest for the treatment of acute deep venous thrombosis Int Angiol 22 2003 393-400
48. Brandjes DP Buller HR Heijboer H et. al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis Lancet 349 1997 759-762
49. Greer I Hunt BJ Low molecular weight heparin in pregnancy: Current issues Br J Haematol 128 2005 593-601
50. Lee AYY Levine MN Baker RI et. al. for the Randomized Comparison of Low-Molecular-Weight Heparin Versus oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2003 146-153
51. Chan WS Anand S Ginsberg JS Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature Arch Intern Med. 160 2000 191-196
52. Oran B Lee-Paritz A Ansell J Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy Thromb Haemost 92 2004 747-751